Based on the Airsculpt Technologies Inc stock forecast from 1 analysts, the average analyst target price for Airsculpt Technologies Inc is USD 3.75 over the next 12 months. Airsculpt Technologies Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Airsculpt Technologies Inc is Bearish, which is based on 3 positive signals and 8 negative signals. At the last closing, Airsculpt Technologies Inc’s stock price was USD 5.35. Airsculpt Technologies Inc’s stock price has changed by -5.81% over the past week, -15.75% over the past month and -26.31% over the last year.
No recent analyst target price found for Airsculpt Technologies Inc
No recent average analyst rating found for Airsculpt Technologies Inc
Company Overview Airsculpt Technologies Inc
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida. Read Less
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure...Read More
Frequently Asked Questions About Airsculpt Technologies Inc (AIRS) Stock
Based on ratings from 1 analysts Airsculpt Technologies Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on AIRS's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for AIRS is USD 3.75 over the next 12 months. The maximum analyst target price is USD 3.75 while the minimum anlayst target price is USD 3.75.
AIRS stock's Price/Earning ratio is 197.00.
Our analysis grades AIRS stock's Price / Earning ratio at F. This means that AIRS stock's Price/Earning ratio is above 88% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this AIRS may be a overvalued for its sector.
The last closing price of AIRS's stock was USD 5.35.
The most recent market capitalization for AIRS is USD 0.38B.
Based on targets from 1 analysts, the average taret price for AIRS is projected at USD 3.75 over the next 12 months.
This means that AIRS's stock price may go down by -29.91% over the next 12 months.
We can't find any ETFs which contains Airsculpt Technologies Inc's stock.
As per our most recent records Airsculpt Technologies Inc has 346 Employees.
Airsculpt Technologies Inc's registered address is 1111 Lincoln Road, Miami Beach, FL, United States, 33139.
You can get more information about it from Airsculpt Technologies Inc's website at https://elitebodysculpture.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Airsculpt Technologies Inc (AIRS) Stock
Based on ratings from 1 analysts Airsculpt Technologies Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on AIRS's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for AIRS is USD 3.75 over the next 12 months. The maximum analyst target price is USD 3.75 while the minimum anlayst target price is USD 3.75.
AIRS stock's Price/Earning ratio is 197.00.
Our analysis grades AIRS stock's Price / Earning ratio at F. This means that AIRS stock's Price/Earning ratio is above 88% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this AIRS may be a overvalued for its sector.
The last closing price of AIRS's stock was USD 5.35.
The most recent market capitalization for AIRS is USD 0.38B.
Based on targets from 1 analysts, the average taret price for AIRS is projected at USD 3.75 over the next 12 months.
This means that AIRS's stock price may go down by -29.91% over the next 12 months.
We can't find any ETFs which contains Airsculpt Technologies Inc's stock.
As per our most recent records Airsculpt Technologies Inc has 346 Employees.
Airsculpt Technologies Inc's registered address is 1111 Lincoln Road, Miami Beach, FL, United States, 33139.
You can get more information about it from Airsculpt Technologies Inc's website at https://elitebodysculpture.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AIRS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
